Hatzoglou A - Search Results

1

Opioids modulate constitutive B-lymphocyte secretion.

Vassou D, Bakogeorgou E, Kampa M, Dimitriou H, Hatzoglou A, Castanas E. Vassou D, et al. Among authors: hatzoglou a. Int Immunopharmacol. 2008 May;8(5):634-44. doi: 10.1016/j.intimp.2008.01.002. Epub 2008 Jan 28. Int Immunopharmacol. 2008. PMID: 18387505

2

Opioids increase bladder cancer cell migration via bradykinin B2 receptors.

Vassou D, Notas G, Hatzoglou A, Castanas E, Kampa M. Vassou D, et al. Among authors: hatzoglou a. Int J Oncol. 2011 Sep;39(3):697-707. doi: 10.3892/ijo.2011.1063. Epub 2011 Jun 3. Int J Oncol. 2011. PMID: 21643624

3

Opioid-somatostatin interactions in regulating cancer cell growth.

Hatzoglou A, Kampa M, Castanas E. Hatzoglou A, et al. Front Biosci. 2005 Jan 1;10:244-56. doi: 10.2741/1524. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15574365 Review.

4

Activation of membrane estrogen receptors induce pro-survival kinases.

Alexaki VI, Charalampopoulos I, Kampa M, Nifli AP, Hatzoglou A, Gravanis A, Castanas E. Alexaki VI, et al. Among authors: hatzoglou a. J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):97-110. doi: 10.1016/j.jsbmb.2005.08.017. Epub 2006 Jan 18. J Steroid Biochem Mol Biol. 2006. PMID: 16414261

5

Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells.

Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E. Kampa M, et al. Among authors: hatzoglou a. Mol Cancer Ther. 2006 May;5(5):1342-51. doi: 10.1158/1535-7163.MCT-05-0527. Mol Cancer Ther. 2006. PMID: 16731768

6

Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action.

Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, Bakogeorgou E, Kouimtzoglou E, Blekas G, Boskou D, Gravanis A, Castanas E. Kampa M, et al. Among authors: hatzoglou a. Breast Cancer Res. 2004;6(2):R63-74. doi: 10.1186/bcr752. Epub 2003 Dec 15. Breast Cancer Res. 2004. PMID: 14979919 Free PMC article.

7

The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line.

Kampa M, Papakonstanti EA, Alexaki VI, Hatzoglou A, Stournaras C, Castanas E. Kampa M, et al. Among authors: hatzoglou a. Exp Cell Res. 2004 Apr 1;294(2):434-45. doi: 10.1016/j.yexcr.2003.11.027. Exp Cell Res. 2004. PMID: 15023532

8

Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation.

Alexaki VI, Charalampopoulos I, Kampa M, Vassalou H, Theodoropoulos P, Stathopoulos EN, Hatzoglou A, Gravanis A, Castanas E. Alexaki VI, et al. Among authors: hatzoglou a. FASEB J. 2004 Oct;18(13):1594-6. doi: 10.1096/fj.04-1495fje. Epub 2004 Aug 2. FASEB J. 2004. PMID: 15289442

9

The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.

Hatzoglou A, Bakogeorgou E, Castanas E. Hatzoglou A, et al. Eur J Pharmacol. 1996 Jan 25;296(2):199-207. doi: 10.1016/0014-2999(95)00703-2. Eur J Pharmacol. 1996. PMID: 8838457

10

Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line.

Hatzoglou A, Bakogeorgou E, Hatzoglou C, Martin PM, Castanas E. Hatzoglou A, et al. Among authors: hatzoglou c. Eur J Pharmacol. 1996 Aug 29;310(2-3):217-23. doi: 10.1016/0014-2999(96)00339-1. Eur J Pharmacol. 1996. PMID: 8884220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page